107 related articles for article (PubMed ID: 21600219)
21. How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors.
Leon K; Garcia K; Carneiro J; Lage A
J Theor Biol; 2007 Jul; 247(1):122-37. PubMed ID: 17412365
[TBL] [Abstract][Full Text] [Related]
22. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
23. Relevance of microenvironmental pH for self-organized tumor growth and invasion.
Kraus M; Severin T; Wolf B
Anticancer Res; 1994; 14(4A):1573-83. PubMed ID: 7979188
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
Talmadge JE; Donkor M; Scholar E
Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
[TBL] [Abstract][Full Text] [Related]
25. The immunologic consequences of laparoscopy in oncology.
Carter JJ; Whelan RL
Surg Oncol Clin N Am; 2001 Jul; 10(3):655-77. PubMed ID: 11685934
[TBL] [Abstract][Full Text] [Related]
26. Cancer and immune response: old and new evidence for future challenges.
de la Cruz-Merino L; Grande-Pulido E; Albero-Tamarit A; Codes-Manuel de Villena ME
Oncologist; 2008 Dec; 13(12):1246-54. PubMed ID: 19056856
[TBL] [Abstract][Full Text] [Related]
27. Kinetic approach and estimation of the parameters of cellular interaction between the immunity system and a tumor.
Kuznetsov VA; Zhivoglyadov VP; Stepanova LA
Arch Immunol Ther Exp (Warsz); 1993; 41(1):21-31. PubMed ID: 8239905
[TBL] [Abstract][Full Text] [Related]
28. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
[TBL] [Abstract][Full Text] [Related]
29. [Function and prognostic significance of immune cells infiltrating human tumors].
Ladányi A
Magy Onkol; 2004; 48(1):49-56. PubMed ID: 15105896
[TBL] [Abstract][Full Text] [Related]
30. Differential equations with applications in cancer diseases.
Ilea M; Turnea M; Rotariu M
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):572-7. PubMed ID: 24340548
[TBL] [Abstract][Full Text] [Related]
31. A reaction-diffusion model of cancer invasion.
Gatenby RA; Gawlinski ET
Cancer Res; 1996 Dec; 56(24):5745-53. PubMed ID: 8971186
[TBL] [Abstract][Full Text] [Related]
32. Human tumor-infiltrating lymphocytes: a marker of host response.
Vose BM; Moore M
Semin Hematol; 1985 Jan; 22(1):27-40. PubMed ID: 3155876
[TBL] [Abstract][Full Text] [Related]
33. Immune responses to human tumors: development of tumor vaccines.
Platsoucas CD; Fincke JE; Pappas J; Jung WJ; Heckel M; Schwarting R; Magira E; Monos D; Freedman RS
Anticancer Res; 2003; 23(3A):1969-96. PubMed ID: 12894571
[TBL] [Abstract][Full Text] [Related]
34. [Current problems in surgical oncology: 1. Theoretical models in oncology and their implications in surgical therapy].
Vasilescu C
Chirurgia (Bucur); 2011; 106(1):17-22. PubMed ID: 21523955
[TBL] [Abstract][Full Text] [Related]
35. Observer-based techniques for the identification and analysis of avascular tumor growth.
Cacace F; Cusimano V; Di Paola L; Germani A
Math Biosci; 2011 Dec; 234(2):147-53. PubMed ID: 22023728
[TBL] [Abstract][Full Text] [Related]
36. Dynamic response of cancer under the influence of immunological activity and therapy.
de Vladar HP; González JA
J Theor Biol; 2004 Apr; 227(3):335-48. PubMed ID: 15019501
[TBL] [Abstract][Full Text] [Related]
37. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
38. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
[TBL] [Abstract][Full Text] [Related]
39. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
40. The possible evolutionary role of tumors in the origin of new cell types.
Kozlov AP
Med Hypotheses; 2010 Jan; 74(1):177-85. PubMed ID: 19665850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
